US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 140.890
  • -1.280-0.90%
Close Apr 18 16:00 ET
8.13BMarket Cap-15482P/E (TTM)

Ascendis Pharma A/S Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
421.20%266.72M
501.42%137.7M
214.15%48.03M
669.37%47.39M
391.93%33.59M
557.93%51.17M
367.55%22.9M
1,273.76%15.29M
502.74%6.16M
815.28%6.83M
Operating revenue
421.20%266.72M
501.42%137.7M
214.15%48.03M
669.37%47.39M
391.93%33.59M
557.93%51.17M
367.55%22.9M
1,273.76%15.29M
502.74%6.16M
815.28%6.83M
Cost of revenue
265.78%44.4M
280.61%19.46M
336.39%7.39M
1,090.52%12.93M
8.83%4.62M
244.51%12.14M
45.10%5.11M
1.69M
1.09M
4.25M
Gross profit
469.52%222.32M
564.90%118.25M
198.93%40.65M
579.23%34.46M
1,021.92%28.97M
817.44%39.04M
1,194.32%17.78M
1,121.65%13.6M
396.48%5.07M
246.11%2.58M
Operating expense
12.82%677.86M
-6.24%154.86M
10.72%175.05M
19.28%175.3M
32.19%172.65M
31.75%600.85M
44.94%165.17M
61.25%158.1M
23.86%146.97M
4.16%130.61M
Selling and administrative expenses
19.52%264.41M
13.13%63.98M
4.85%63.61M
24.21%70.28M
40.32%66.54M
38.11%221.23M
17.08%56.55M
54.44%60.67M
60.09%56.58M
27.31%47.42M
Research and development costs
8.91%413.45M
-16.33%90.88M
14.38%111.44M
16.20%105.02M
27.55%106.11M
28.31%379.62M
65.45%108.62M
65.81%97.43M
8.50%90.38M
-5.62%83.19M
Operating profit
18.92%-455.54M
75.16%-36.61M
6.99%-134.41M
0.74%-140.84M
-12.23%-143.69M
-24.35%-561.81M
-30.92%-147.39M
-49.08%-144.51M
-20.63%-141.89M
-2.71%-128.03M
Net non-operating interest income expense
-16.99%-27.21M
4.35%-68.55M
2.60%-20.38M
-57.16%26.43M
361.67%35.3M
-622.46%-23.26M
-58.47%-71.67M
-202.33%-20.92M
614.28%61.69M
-77.22%7.65M
Non-operating interest income
127.00%16.86M
9.41%-60.13M
-79.62%4.14M
-49.72%35.76M
246.02%45.14M
973.12%7.43M
-51.20%-66.37M
-4.67%20.33M
48,953.10%71.13M
-62.11%13.04M
Non-operating interest expense
43.62%44.07M
58.93%8.43M
-40.56%24.52M
-1.06%9.33M
82.26%9.84M
684.51%30.68M
298.27%5.3M
4,603.19%41.25M
-22.30%9.43M
521.29%5.4M
Other net income (expense)
18.64%8.61M
41.72%24.08M
-83.82%-6.79M
-539.02%-7.45M
74.82%-1.23M
-89.79%7.25M
-67.10%16.99M
4.12%-3.7M
75.79%-1.17M
-117.34%-4.87M
Gain on sale of security
8.22%27M
----
----
----
----
-57.73%24.95M
----
----
----
----
Earnings from equity interest
-3.94%-18.4M
63.27%-2.92M
-83.82%-6.79M
-539.02%-7.45M
74.82%-1.23M
-246.97%-17.7M
-7.68%-7.96M
4.12%-3.7M
75.79%-1.17M
-117.34%-4.87M
Income before tax
17.94%-474.14M
59.87%-81.09M
4.46%-161.58M
-49.77%-121.86M
12.49%-109.62M
-50.50%-577.82M
-90.32%-202.07M
-110.50%-169.12M
39.48%-81.37M
-98.87%-125.26M
Income tax
35.82%7.3M
8.24%5.79M
486.23%645K
-812.77%-429K
438.17%1.3M
1,565.12%5.38M
4,792.11%5.35M
-3,440.00%-167K
30.88%-47K
226.18%241K
Net income
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
-110.28%-168.96M
39.48%-81.32M
-99.86%-125.5M
Net income continuous Operations
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
-110.28%-168.96M
39.48%-81.32M
-99.86%-125.5M
Minority interest income
Net income attributable to the parent company
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
-110.28%-168.96M
39.48%-81.32M
-99.86%-125.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
-110.28%-168.96M
39.48%-81.32M
-99.86%-125.5M
Basic earnings per share
17.79%-8.55
58.38%-1.54
4.95%-2.88
-47.95%-2.16
10.41%-1.98
-48.57%-10.4
-97.86%-3.7
-106.12%-3.03
41.60%-1.46
-88.89%-2.21
Diluted earnings per share
17.79%-8.55
58.38%-1.54
4.95%-2.88
-47.95%-2.16
10.41%-1.98
-48.57%-10.4
-97.86%-3.7
-106.12%-3.03
41.60%-1.46
-88.89%-2.21
Dividend per share
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 421.20%266.72M501.42%137.7M214.15%48.03M669.37%47.39M391.93%33.59M557.93%51.17M367.55%22.9M1,273.76%15.29M502.74%6.16M815.28%6.83M
Operating revenue 421.20%266.72M501.42%137.7M214.15%48.03M669.37%47.39M391.93%33.59M557.93%51.17M367.55%22.9M1,273.76%15.29M502.74%6.16M815.28%6.83M
Cost of revenue 265.78%44.4M280.61%19.46M336.39%7.39M1,090.52%12.93M8.83%4.62M244.51%12.14M45.10%5.11M1.69M1.09M4.25M
Gross profit 469.52%222.32M564.90%118.25M198.93%40.65M579.23%34.46M1,021.92%28.97M817.44%39.04M1,194.32%17.78M1,121.65%13.6M396.48%5.07M246.11%2.58M
Operating expense 12.82%677.86M-6.24%154.86M10.72%175.05M19.28%175.3M32.19%172.65M31.75%600.85M44.94%165.17M61.25%158.1M23.86%146.97M4.16%130.61M
Selling and administrative expenses 19.52%264.41M13.13%63.98M4.85%63.61M24.21%70.28M40.32%66.54M38.11%221.23M17.08%56.55M54.44%60.67M60.09%56.58M27.31%47.42M
Research and development costs 8.91%413.45M-16.33%90.88M14.38%111.44M16.20%105.02M27.55%106.11M28.31%379.62M65.45%108.62M65.81%97.43M8.50%90.38M-5.62%83.19M
Operating profit 18.92%-455.54M75.16%-36.61M6.99%-134.41M0.74%-140.84M-12.23%-143.69M-24.35%-561.81M-30.92%-147.39M-49.08%-144.51M-20.63%-141.89M-2.71%-128.03M
Net non-operating interest income expense -16.99%-27.21M4.35%-68.55M2.60%-20.38M-57.16%26.43M361.67%35.3M-622.46%-23.26M-58.47%-71.67M-202.33%-20.92M614.28%61.69M-77.22%7.65M
Non-operating interest income 127.00%16.86M9.41%-60.13M-79.62%4.14M-49.72%35.76M246.02%45.14M973.12%7.43M-51.20%-66.37M-4.67%20.33M48,953.10%71.13M-62.11%13.04M
Non-operating interest expense 43.62%44.07M58.93%8.43M-40.56%24.52M-1.06%9.33M82.26%9.84M684.51%30.68M298.27%5.3M4,603.19%41.25M-22.30%9.43M521.29%5.4M
Other net income (expense) 18.64%8.61M41.72%24.08M-83.82%-6.79M-539.02%-7.45M74.82%-1.23M-89.79%7.25M-67.10%16.99M4.12%-3.7M75.79%-1.17M-117.34%-4.87M
Gain on sale of security 8.22%27M-----------------57.73%24.95M----------------
Earnings from equity interest -3.94%-18.4M63.27%-2.92M-83.82%-6.79M-539.02%-7.45M74.82%-1.23M-246.97%-17.7M-7.68%-7.96M4.12%-3.7M75.79%-1.17M-117.34%-4.87M
Income before tax 17.94%-474.14M59.87%-81.09M4.46%-161.58M-49.77%-121.86M12.49%-109.62M-50.50%-577.82M-90.32%-202.07M-110.50%-169.12M39.48%-81.37M-98.87%-125.26M
Income tax 35.82%7.3M8.24%5.79M486.23%645K-812.77%-429K438.17%1.3M1,565.12%5.38M4,792.11%5.35M-3,440.00%-167K30.88%-47K226.18%241K
Net income 17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M-110.28%-168.96M39.48%-81.32M-99.86%-125.5M
Net income continuous Operations 17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M-110.28%-168.96M39.48%-81.32M-99.86%-125.5M
Minority interest income
Net income attributable to the parent company 17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M-110.28%-168.96M39.48%-81.32M-99.86%-125.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M-110.28%-168.96M39.48%-81.32M-99.86%-125.5M
Basic earnings per share 17.79%-8.5558.38%-1.544.95%-2.88-47.95%-2.1610.41%-1.98-48.57%-10.4-97.86%-3.7-106.12%-3.0341.60%-1.46-88.89%-2.21
Diluted earnings per share 17.79%-8.5558.38%-1.544.95%-2.88-47.95%-2.1610.41%-1.98-48.57%-10.4-97.86%-3.7-106.12%-3.0341.60%-1.46-88.89%-2.21
Dividend per share
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg